Yiqiang Zhou

Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism

Di Yu, Yang Liu, Yiqiang Zhou et al. · Proceedings of the National Academy of Sciences · 2020 · 146 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis

Pengcheng Luo, Hsin-Hsin Chang, Yiqiang Zhou et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 119 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose

Teer Ba, Jin‐Yuan Ho, Dandan Chen et al. · Frontiers in Oncology · 2021 · 99 citations · Full text

Medicine, Immunology, Oncology +17

Targeting IDH1-Mutated Malignancies with NRF2 Blockade

Yang Liu, Yanxin Lu, Orieta Celiku et al. · JNCI Journal of the National Cancer Institute · 2018 · 92 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to <i>SDHB</i> -Mutated Cluster I Pheochromocytoma and Paraganglioma

Ying Pang, Yanxin Lu, Veronika Caisová et al. · Clinical Cancer Research · 2018 · 72 citations · Full text

Medicine, Molecular Biology, Oncology +17